WeVote
Log In

Bill

Bill

A 7175

Expands insurance coverage for in vitro fertilization to include three complete oocyte retrievals and in vitro fertilization with unlimited embryo transfers; includes coverage under individual policies

2025 Regular Session Introduced by Rodneyse Bichotte Hermelyn

Expands private health insurance to cover three oocyte retrievals and IVF with unlimited embryo transfers, widening access to IVF for individuals with private policies.

REFERRED TO INSURANCE
0
WeVote Research Nonpartisan
Bill Summary · A 7175

Summary: Assembly Bill A 7175

Overview

  • Bill number: A 7175
  • Title/Purpose (as stated): Expands insurance coverage for in vitro fertilization (IVF) to include three complete oocyte retrievals and IVF with unlimited embryo transfers; coverage applies to individual (private) policies.
  • Introduced: March 21, 2025
  • Primary sponsor: Rodneyse Bichotte Hermelyn
  • Status: REFERRED TO INSURANCE (as of introduction)
  • Related bills: A 10588 (prior-session); S 5734 (companion) — both Senate counterparts are noted as companions

What the bill would do (Key Provisions)

  • Mandates or expands IVF insurance coverage to:
    • Include three complete oocyte retrievals per coverage period or policy, expanding access to multiple IVF cycles.
    • Allow IVF with unlimited embryo transfers, removing or lifting caps on embryo transfers within IVF treatment plans.
    • Applies to individual private health insurance policies (as opposed to only group plans or public programs).

Note: The description provided does not specify details such as copayments, deductibles, lifetime or annual caps, age limits, or clinical criteria for coverage. The summary reflects the language given: three oocyte retrievals and unlimited embryo transfers under individual policies.

Who would be affected

  • Individuals who hold private, individual health insurance policies would gain expanded IVF coverage.
  • Healthcare providers and fertility clinics would interact with insurers under the expanded terms.
  • Insurance issuers would need to adjust policy language, claims processing, and policy rider language to comply.

Procedural and timeline aspects

  • Status: In the early stage of the legislative process, referred to the Assembly Committee on Insurance.
  • Actions noted: Two identical entries on 2025-03-21 both indicate “REFERRED TO INSURANCE,” suggesting placement in the Insurance Committee for consideration.
  • Next steps: The bill would advance through committee hearings, potential amendments, and then floor votes in the Assembly. If approved, it would move to the Senate for consideration and potential companion action (S 5734).

Relationship to related bills

  • A 10588 (prior-session): Indicates a prior Assembly proposal on IVF coverage, suggesting ongoing legislative interest in this policy area.
  • S 5734 (companion): Senate counterpart, indicating cross-chamber support and alignment with the Assembly action for parallel policy changes.

Potential impact and considerations

  • Access and equity: Could significantly improve access to IVF for individuals relying on private insurance, potentially reducing out-of-pocket costs for multiple cycles.
  • Cost implications: Insurers may face higher short-term costs due to additional covered procedures; long-term effects would depend on utilization, clinical outcomes, and premium adjustments.
  • Policy design questions (not specified): Whether there are age limits, clinical criteria, step-therapy requirements, documentation standards, or caps beyond the stated three retrievals and unlimited transfers.

Notes

  • As introduced, the bill’s concrete provisions beyond the stated scope (three oocyte retrievals and unlimited embryo transfers under individual policies) are not detailed in the provided information. Readers should monitor committee reports for exact language, exemptions, and implementation timelines if the bill advances.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.